What Are the Therapeutic Implications of Targeting Genome Integrity?
Targeting genome integrity has therapeutic implications in cancer treatment. Inhibitors of PARP (poly ADP-ribose polymerase) have shown efficacy in treating cancers with BRCA mutations by exploiting the concept of synthetic lethality. Additionally, strategies to enhance DNA repair capacity or protect genome integrity could be used to prevent cancer development in high-risk individuals.